Literature DB >> 8311452

Characterization of the human placental membrane receptor for transcobalamin II-cobalamin.

E V Quadros1, P Sai, S P Rothenberg.   

Abstract

A specific receptor on the plasma membrane of mammalian cells facilitates the uptake of vitamin B12 (cobalamin, Cbl) by receptor-mediated endocytosis of transcobalamin II-bound Cbl (TCII-Cbl). Purification of this receptor has proven to be difficult because of the lability of the protein during solubilization. Using human placental membranes as the source of the receptor, we have investigated alternative methods for solubilization of this protein and characterized a number of functional and structural properties. Homogenized and washed placental membranes show specific, saturable binding of TCII-Cbl with a Ka of 0.26 nM-1. Following solubilization of the membranes in 3-[(3-cholamidopropyl)-dimethylammonio]-2-hydroxy-1-propanesulfonate (CHAPSO), the most efficient nonionic detergent tested, 21% of the receptor activity remained with the residual insoluble membrane fraction, a property of membrane proteins that are bound tightly to the cell cytoskeleton. Whereas 10 mM Chapso removed 79% of the receptor activity from the membrane preparation, only 3.7% of the TCII-Cbl binding activity was recovered in the solubilized fraction. The unstable TCII-Cbl binding in the soluble fraction was protected by the addition of 15% glycerol to the preparation and storage at -20 degrees C. The apparent M(r) of the receptor estimated by SDS-PAGE of the crosslinked receptor 125I-TCII-Cbl is approximately 58,000. The decrease in M(r) following digestion with several glycosidases and neuraminidase indicates that approximately 29% of the protein is carbohydrate which accounts for a core polypeptide of 41 kDa. Selective binding to a battery of lectins has established that the carbohydrate moiety of the receptor contains a large proportion of N-acetylglucosamine and terminal X-linked mannose.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8311452     DOI: 10.1006/abbi.1994.1027

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

Review 1.  Cellular uptake of cobalamin: transcobalamin and the TCblR/CD320 receptor.

Authors:  Edward V Quadros; Jeffrey M Sequeira
Journal:  Biochimie       Date:  2013-02-14       Impact factor: 4.079

Review 2.  Advances in the understanding of cobalamin assimilation and metabolism.

Authors:  Edward V Quadros
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

3.  Mapping the functional domains of TCblR/CD320, the receptor for cellular uptake of transcobalamin-bound cobalamin.

Authors:  Wenxia Jiang; Yasumi Nakayama; Jeffrey M Sequeira; Edward V Quadros
Journal:  FASEB J       Date:  2013-04-19       Impact factor: 5.191

4.  The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin.

Authors:  Edward V Quadros; Yasumi Nakayama; Jeffrey M Sequeira
Journal:  Blood       Date:  2008-09-08       Impact factor: 22.113

5.  Transcellular transport of cobalamin in aortic endothelial cells.

Authors:  Luciana Hannibal; Keerthana Bolisetty; Armend Axhemi; Patricia M DiBello; Edward V Quadros; Sergey Fedosov; Donald W Jacobsen
Journal:  FASEB J       Date:  2018-05-09       Impact factor: 5.191

6.  Structural basis of transcobalamin recognition by human CD320 receptor.

Authors:  Amer Alam; Jae-Sung Woo; Jennifer Schmitz; Bernadette Prinz; Katharina Root; Fan Chen; Joël S Bloch; Renato Zenobi; Kaspar P Locher
Journal:  Nat Commun       Date:  2016-07-14       Impact factor: 14.919

Review 7.  Interaction between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies.

Authors:  Manon D Owen; Bernadette C Baker; Eleanor M Scott; Karen Forbes
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Cobalamin analogues in humans: a study on maternal and cord blood.

Authors:  Tore Forsingdal Hardlei; Rima Obeid; Wolfgang Herrmann; Ebba Nexo
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

9.  A missense mutation in TCN2 is associated with decreased risk for congenital heart defects and may increase cellular uptake of vitamin B12 via Megalin.

Authors:  Peiqiang Li; Lijuan Huang; Yufang Zheng; Xuedong Pan; Rui Peng; Yueming Jiang; Richard H Finnell; Haijie Li; Bin Qiao; Hong-Yan Wang
Journal:  Oncotarget       Date:  2017-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.